Methenamine Hippurate Orion

Active Ingredient:: Methenamine Hippurate
Origin:: EU

Methenamine Hippurate Orion (Methenamine Hippurate)

Q: What is Methenamine Hippurate Orion used for?

Methenamine Hippurate Orion is used to help prevent recurrent urinary tract infections and may be added to antibiotic regimens as an adjunctive therapy for uncomplicated urinary infections. It works by creating an acidic urinary environment that limits bacterial growth.

Q: How does methenamine hippurate work in the body?

When urine is sufficiently acidic, methenamine hippurate breaks down to release formaldehyde. Formaldehyde is a broad‑spectrum antimicrobial that damages bacterial proteins and DNA, thereby reducing or eliminating urinary pathogens.

Q: What is the usual dose of methenamine hippurate?

The specific dose and dosing schedule of methenamine hippurate are determined by the prescribing clinician based on the patient’s condition, renal function, and urinary pH. No universal dosing regimen is provided here.

Q: Is methenamine hippurate safe during pregnancy or breastfeeding?

Safety data for methenamine hippurate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

Q: How do I order Methenamine Hippurate Orion from GNH India?

To order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Q: How does methenamine hippurate compare with other urinary antiseptics?

Methenamine hippurate differs from other urinary antiseptics by relying on urinary acidification to generate formaldehyde in situ. Unlike antibiotics, it does not target specific bacterial species, making it useful for prophylaxis, whereas other agents may require systemic absorption or have broader antimicrobial spectra.

Q: What are the storage requirements for Methenamine Hippurate Orion?

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Q: How is Methenamine Hippurate Orion administered?

Methenamine Hippurate Orion is taken orally, usually as a tablet, with or without food as directed by the prescriber. Adequate fluid intake is recommended to maintain urinary output and support the drug’s mechanism.

Q: What are the most serious risks associated with methenamine hippurate?

Serious risks include severe allergic reactions such as anaphylaxis, hematuria, renal impairment, hepatic dysfunction, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience signs of these reactions.

Q: Who should not use methenamine hippurate?

Methenamine hippurate should be avoided in patients with severe renal or hepatic impairment, those with known hypersensitivity to the drug, and individuals whose urine cannot be acidified (e.g., due to concurrent alkalinizing therapy).

Methenamine Hippurate, the active ingredient in Methenamine Hippurate Orion, is a urinary antiseptic presented as an oral tablet for oral use. It is employed to help prevent recurrent urinary tract infections and may be used as an adjunct in uncomplicated urinary infections.

GNH India supplies Methenamine Hippurate Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methenamine Hippurate is used in the urinary tract infection pathway to reduce bacterial growth.

Prevention of recurrent urinary tract infections: helps lower the frequency of infections by maintaining an acidic urinary environment that limits bacterial proliferation.
Adjunctive treatment of uncomplicated urinary tract infections: used together with appropriate antibiotics to enhance bacterial eradication in acidic urine.

How It Works

In acidic urine (pH < 6), methenamine hippurate hydrolyzes to release formaldehyde, a potent antimicrobial agent. The generated formaldehyde disrupts bacterial proteins and nucleic acids, leading to bacterial cell death and inhibition of urinary pathogens.

Side Effects

Methenamine Hippurate may cause a range of adverse reactions.

Common Side Effects

Nausea: mild to moderate stomach upset.
Vomiting: occasional expulsion of stomach contents.
Dyspepsia: discomfort or pain in the upper abdomen.
Abdominal pain: cramping or tenderness.
Headache: transient head discomfort.
Metallic taste: altered taste sensation.

Serious or Rare Side Effects

Severe allergic reaction (anaphylaxis): difficulty breathing, swelling, rash.
Hematuria: presence of blood in urine.
Renal impairment: reduced kidney function.
Hepatic dysfunction: abnormal liver enzymes.
Stevens‑Johnson syndrome: severe skin reaction.
Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

Precautions & Warnings

Before prescribing methenamine hippurate, consider the following safety measures.

Assess renal function: ensure adequate kidney function before initiating therapy.
Monitor urinary pH: effectiveness requires acidic urine (pH < 6).
Avoid in severe liver disease: hepatic impairment may affect drug metabolism.
Use caution in pregnancy: safety has not been established.
Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Avoid Interactions

Methenamine hippurate can interact with other medicines that alter urinary pH or renal handling.

Major Interactions (Avoid)

Alkalinizing agents (e.g., sodium bicarbonate): raise urinary pH, reducing drug activation.
Antacids containing magnesium or aluminum: increase urinary pH, decreasing efficacy.
Probenecid: may increase systemic methenamine levels.

Moderate Interactions (Monitor Closely)

Aminoglycoside antibiotics: additive risk of nephrotoxicity.
Loop diuretics: may change urinary concentration and affect drug activity.

Frequently Asked Questions

Methenamine Hippurate Orion is used to help prevent recurrent urinary tract infections and may be added to antibiotic regimens as an adjunctive therapy for uncomplicated urinary infections. It works by creating an acidic urinary environment that limits bacterial growth.

When urine is sufficiently acidic, methenamine hippurate breaks down to release formaldehyde. Formaldehyde is a broad‑spectrum antimicrobial that damages bacterial proteins and DNA, thereby reducing or eliminating urinary pathogens.

The specific dose and dosing schedule of methenamine hippurate are determined by the prescribing clinician based on the patient’s condition, renal function, and urinary pH. No universal dosing regimen is provided here.

Safety data for methenamine hippurate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Methenamine hippurate differs from other urinary antiseptics by relying on urinary acidification to generate formaldehyde in situ. Unlike antibiotics, it does not target specific bacterial species, making it useful for prophylaxis, whereas other agents may require systemic absorption or have broader antimicrobial spectra.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Methenamine Hippurate Orion is taken orally, usually as a tablet, with or without food as directed by the prescriber. Adequate fluid intake is recommended to maintain urinary output and support the drug’s mechanism.

Serious risks include severe allergic reactions such as anaphylaxis, hematuria, renal impairment, hepatic dysfunction, and rare skin conditions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience signs of these reactions.

Methenamine hippurate should be avoided in patients with severe renal or hepatic impairment, those with known hypersensitivity to the drug, and individuals whose urine cannot be acidified (e.g., due to concurrent alkalinizing therapy).

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 06 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.